Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1142.60 -63.40 (-5.26%)

51.15% Gain from 52W Low

233.0K NSE+BSE Volume

NSE 16 May, 2025 3:31 PM (IST)

14,011.6

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Rapid Results

Q4FY25 & FY25 Result Announced for Alivus Life Sciences Ltd. See details

Alivus Life Sciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alivus Life Sciences Ltd. from all sources in a single place.

Load latest

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

123 Votes:

Buy 75.61%

Sell 13.01%

Hold 11.38%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >